Radiography News
-
Ultravist by Bayer now approved for contrast-enhanced mammography in EU
Ultravist-300, -370 receives green light for indication extension for use in contrast-enhanced mammography (CEM) in a European Workshare Procedure CEM is emerging modality combining digital mammography with the administration of a contrast agent Strategically expands Bayer’s portfolio in breast imaging, including contrast agents and injectors Bayer announced today that its ...
By Bayer AG
-
Prof. Krestin Joins Fluidda’S Board of Directors
INTRODUCTION Gabriel Krestin received his MD from the University of Cologne, Germany where he also specialized in radiology, in 1981 and his PhD (Habilitation) in 1989. From 1990–1997, he worked at the University Hospital in Zürich/CH, including a period as acting chairman of the Department of Radiology. In 1997 he moved to Erasmus MC in Rotterdam, Netherlands where he was the ...
By Fluidda
-
Breast Cancer Awareness Month: Let Our Family Protect Your Family
October marks a month dedicated to a cause close to the core of everything which we do at Cirdan: Breast Cancer Awareness. This month will see a surge in activism surrounding breast cancer awareness and a push for finding a cure from around the globe. The fight to treat and cure breast cancer continues constantly, and we pride ourselves in taking part in the fight to save lives. Breast cancer ...
By Cirdan Ltd
-
Cerapedics Announces FDA approval of an IDE supplement
Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for the on-going clinical trial, ASPIRE, for P-15L Bone Graft in a single level transforaminal lumbar interbody fusion (TLIF) surgery. “We are pleased to announce ...
-
Cerapedics Announces Results from Clinical Trial of i-FACTOR Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide Enhanced Bone Graft in non-instrumented lumbar fusion surgery has been published in the May 2020, Volume 20, Issue 5 print of The Spine Journal as the lead article. The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a ...
-
Medimprove – A New Private Clinic For Lung Revalidation With FRI
To address the need for better chronic respiratory care, Prof De Backer, emeritus Professor Pulmonology at the University of Antwerp and Chairman of The board of FLUIDDA NV, has opened a private clinic in Belgium near the Fluidda headquarters in Kontich, Belgium. The clinic uses a multidisciplinary approach for chronic respiratory failure. Care at this private clinic can involve exercise ...
By Fluidda
-
SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors
WATERTOWN, Mass.--(BUSINESS WIRE)-- SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the company’s lead cell therapy candidate, SQZ-PBMC-HPV, for the treatment of HPV16+ advanced or metastatic solid tumors. Fast ...
-
Align Technology Announces Record Fourth Quarter and Fiscal 2021 Financial Results
Strengthens Align digital platform with major installed base milestones including 12M Invisalign patients, 68K iTero scanners, and 47K exocad software licenses 2021 total revenues up 59.9% to a record $4.0 billion, operating margin of 24.7%, in line with guidance 2021 revenue growth for the second half was 30.5% compared to 2020, at high-end of 20% to 30% target, in line with guidance 2021 ...
-
Subtle Medical to Become the First Partner Siemens Healthineers Welcomes on Board Their New Open Recon¹ Interface
Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, announced today a partnership to integrate Subtle Medical’s SubtleMR™ image-enhancement software into the MRI machines of Siemens Healthineers. SubtleMR™ will be incorporated into the planned reconstruction pipeline of ...
-
VUNO Signs Another Deal with Samsung Electronics
VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung’s Premium Ceiling Type Digital Radiography System October 6, 2021 – South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO’s artificial ...
By Vuno Inc.
-
Lyra Therapeutics Announces Publication of Positive LANTERN Results in the International Forum of Allergy & Rhinology
Company to Initiate Phase 3 ENLIGHTEN Program around YE’21 Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that the positive results of the Company’s Phase ...
-
Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs. Local Autologous Bone in ACDF Surgery
Cerapedics Inc., a private ortho-biologics company dedicated to enhancing the science of bone repair, announced today that results of a study to evaluate the cost-effectiveness of i-FACTOR Peptide Enhanced Bone Graft compared to autograft for patients undergoing ACDF surgery were recently published in ClinicoEconomics and Outcomes Research (July 2021, Volume 2021, Issue 13). In this landmark ...
-
Carlsmed and the International Spine Study Group Foundation Announce Long-term Partnership
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc., a commercial stage medical device technology company, is announcing today that it has partnered with the International Spine Study Group Foundation (ISSGF), the premier study group on adult spinal deformity, to collect data on surgical treatment with personalized interbody devices. Long term outcomes data will be collected to assess the role of ...
-
AI Specialists Manchester Imaging Win UK Innovation Scholars Grant to Develop AI-enhanced Skin Cancer Detection Capability for Michelson Diagnostics’ VivoSight OCT Scanner
AI specialists Manchester Imaging Ltd have won a UK Innovation Scholars grant to support the parttime secondment of AI expert Tom Williams to skin scanner specialists Michelson Diagnostics Ltd over two years. Tom is working with Michelson to develop AI software that will process images of basal cell carcinoma, the most common form of skin cancer affecting millions worldwide, scanned by ...
-
Epica International Announces Operations in Spartanburg, S.C. USA
Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. What: Epica International, with offices in San Clemente, California and manufacturing and R&D facilities in Florence and Pisa, Italy ...
-
Epica International Announces Operations in Spartanburg, S.C. USA
SPARTANBURG, SC – MAY 13, 2021 – Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. WHAT: Epica International, with offices in San Clemente, California and manufacturing and R&D ...
-
VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung’s Premium Mobile X-ray System
VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung’s Premium Mobile X-ray System VUNO’s road-tested, clinically-proven chest X-ray detection software is reshaping the delivery of medical imaging diagnostics by being fully integrated with Samsung Electronics’ X-ray system June 25, 2021 - South Korean artificial intelligence (AI) developer, VUNO ...
By Vuno Inc.
-
Artificial Intelligence Fuels Unprecedented Neurosurgical Progress, with Broad Potential Impact
With a deepening focus on unleashing novel applications of artificial intelligence (AI) across—and beyond—neurosurgery, a multidisciplinary team of physicians and mathematicians are collaborating on advanced approaches to diagnosis and patient care, developing data-driven methods that hold potential for progress across the continuum of medicine. A Specialty Uniquely Poised to Lead ...
-
Cerapedics Announces Commercial Launch of i-FACTOR+ Matrix in Canada
Cerapedics, a private ortho-biologics company, today announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. “We are excited to announce that i-FACTOR+ Matrix is now fully available in Canada through our distributor Surgi-One and can be used in both spine and general orthopedic applications,” said Glen Kashuba, Chief Executive Officer of ...
-
Cerapedics Announces Canadian Approval of its next-generation bone graft
Cerapedics, a private ortho-biologics company, today announced the Health Canada approval of the company’s next-generation bone graft called i-FACTOR+ Matrix, making it the first market to approve the commercial launch of this product. “We are excited to announce Canadian regulatory approval of our next-generation product, based on P15 osteogenic cell-binding peptide , i-FACTOR+ ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you